[1] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志,2019,47(10):766-783. [2] 叶建熙,陈瑾,刘燕,等. 体外膜肺氧合联合主动脉内球囊反搏对行经皮冠状动脉介入术治疗急性心肌梗死合并心源性休克患者疗效[J].临床军医杂志,2021,49(10):1162-1164. [3] 周亮,邵敏,王昌会,等. 接受体外膜肺氧合治疗患者预后的影响因素研究[J].实用心脑肺血管病杂志,2020,28(9):46-51. [4] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220. [5] Panchal AR, Bartos JA, Cabañas JG, et al.Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J]. Circulation, 2020, 142(16_Suppl_2):S366-S468. [6] Riva G, Ringh M, Jonsson M, et al.Survival in out-of-hospital cardiac arrest after standard cardiopulmonary resuscitation or chest compressions only before arrival of emergency medical services: nationwide study during three guideline periods[J]. Circulation, 2019, 139(23): 2600-2609. [7] 中国医师协会体外生命支持专业委员会. 成人体外膜氧合循环辅助专家共识[J].中华重症医学电子杂志(网络版),2018,4(2):114-122. [8] Dennis M, McCanny P, D'Souza M, et al. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: a multicentre experience[J]. Int J Cardiol, 2017, 231: 131-136. [9] 吴颖,张励庭,冯力,等. 体外膜肺氧合联合急诊经皮冠状动脉介入治疗抢救急性心肌梗死后心脏骤停患者的临床疗效及其影响因素分析[J].中国循环杂志,2018,33(6):561-566. |